Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
Missing lot numbers on the vial or the paperwork
For general wellness or anti-aging purposes, many protocols use about 50-100 mg of NAD+ per injection, given a few times per week
Mechanism of Action Stimulates lipolysis via 3-adrenergic receptor-like activation
Faster tissue repair of the injury and full training capacity are the primary reasons athletes seek BPC-157 for muscle growth and recovery
Durham Peptides also carries for researchers studying NAD+ biology directly